Smooth Muscle Research Group and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta T2N 4Z6, Canada.
J Biol Chem. 2012 Oct 19;287(43):36356-69. doi: 10.1074/jbc.M112.398479. Epub 2012 Sep 4.
Ca(2+) sensitization of smooth muscle contraction depends upon the activities of protein kinases, including Rho-associated kinase, that phosphorylate the myosin phosphatase targeting subunit (MYPT1) at Thr(697) and/or Thr(855) (rat sequence numbering) to inhibit phosphatase activity and increase contractile force. Both Thr residues are preceded by the sequence RRS, and it has been suggested that phosphorylation at Ser(696) prevents phosphorylation at Thr(697). However, the effects of Ser(854) and dual Ser(696)-Thr(697) and Ser(854)-Thr(855) phosphorylations on myosin phosphatase activity and contraction are unknown. We characterized a suite of MYPT1 proteins and phosphospecific antibodies for specificity toward monophosphorylation events (Ser(696), Thr(697), Ser(854), and Thr(855)), Ser phosphorylation events (Ser(696)/Ser(854)) and dual Ser/Thr phosphorylation events (Ser(696)-Thr(697) and Ser(854)-Thr(855)). Dual phosphorylation at Ser(696)-Thr(697) and Ser(854)-Thr(855) by cyclic nucleotide-dependent protein kinases had no effect on myosin phosphatase activity, whereas phosphorylation at Thr(697) and Thr(855) by Rho-associated kinase inhibited phosphatase activity and prevented phosphorylation by cAMP-dependent protein kinase at the neighboring Ser residues. Forskolin induced phosphorylation at Ser(696), Thr(697), Ser(854), and Thr(855) in rat caudal artery, whereas U46619 induced Thr(697) and Thr(855) phosphorylation and prevented the Ser phosphorylation induced by forskolin. Furthermore, pretreatment with forskolin prevented U46619-induced Thr phosphorylations. We conclude that cross-talk between cyclic nucleotide and RhoA signaling pathways dictates the phosphorylation status of the Ser(696)-Thr(697) and Ser(854)-Thr(855) inhibitory regions of MYPT1 in situ, thereby regulating the activity of myosin phosphatase and contraction.
钙离子敏感受体依赖蛋白激酶(如 ROCK)来调节平滑肌的收缩,这些蛋白激酶可以使肌球蛋白磷酸酶的靶向亚基(MYPT1)的 Thr(697)和/或 Thr(855)磷酸化(大鼠序列编号),从而抑制磷酸酶的活性并增加收缩力。这两个 Thr 残基都位于 RRS 序列之前,有研究表明 Thr(697)的磷酸化会阻止 Ser(696)的磷酸化。然而,Ser(854)和 Ser(696)-Thr(697)以及 Ser(854)-Thr(855)双重磷酸化对肌球蛋白磷酸酶活性和收缩的影响尚不清楚。我们对 MYPT1 蛋白及其磷酸化特异性抗体进行了一系列研究,以确定它们对单磷酸化事件(Ser(696)、Thr(697)、Ser(854)和 Thr(855))、Ser 磷酸化事件(Ser(696)/Ser(854))和 Ser/Thr 双重磷酸化事件(Ser(696)-Thr(697)和 Ser(854)-Thr(855))的特异性。环核苷酸依赖性蛋白激酶对 Ser(696)-Thr(697)和 Ser(854)-Thr(855)的双重磷酸化对肌球蛋白磷酸酶活性没有影响,而 ROCK 激酶对 Thr(697)和 Thr(855)的磷酸化抑制了磷酸酶的活性,并阻止了 cAMP 依赖性蛋白激酶在相邻 Ser 残基上的磷酸化。forskolin 诱导大鼠尾动脉中 Ser(696)、Thr(697)、Ser(854)和 Thr(855)的磷酸化,而 U46619 诱导 Thr(697)和 Thr(855)的磷酸化,并阻止 forskolin 诱导的 Ser 磷酸化。此外,forskolin 的预处理可以防止 U46619 诱导的 Thr 磷酸化。我们的结论是,环核苷酸和 RhoA 信号通路之间的串扰决定了 MYPT1 的 Ser(696)-Thr(697)和 Ser(854)-Thr(855)抑制区在体内的磷酸化状态,从而调节肌球蛋白磷酸酶的活性和收缩。